208 related articles for article (PubMed ID: 12789153)
1. Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations.
Tsai CH; Hsieh YS; Yang SF; Chou MY; Chang YC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):710-6. PubMed ID: 12789153
[TBL] [Abstract][Full Text] [Related]
2. Regulation of matrix metalloproteinase-2 production by cytokines and pharmacological agents in human pulp cell cultures.
Chang YC; Yang SF; Hsieh YS
J Endod; 2001 Nov; 27(11):679-82. PubMed ID: 11716080
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
Yorioka CW; Coletta RD; Alves F; Nishimoto IN; Kowalski LP; Graner E
Int J Oncol; 2002 Jan; 20(1):189-94. PubMed ID: 11743663
[TBL] [Abstract][Full Text] [Related]
5. The matrix metalloproteinase system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer.
Sharwani A; Jerjes W; Hopper C; Lewis MP; El-Maaytah M; Khalil HS; Macrobert AJ; Upile T; Salih V
Arch Oral Biol; 2006 Dec; 51(12):1104-11. PubMed ID: 16889746
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
8. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
10. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL
Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433
[TBL] [Abstract][Full Text] [Related]
12. A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line.
Lee BK; Kim MJ; Jang HS; Lee HR; Ahn KM; Lee JH; Choung PH; Kim MJ
In Vivo; 2008; 22(5):593-7. PubMed ID: 18853752
[TBL] [Abstract][Full Text] [Related]
13. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
Ikeda M; Maekawa R; Tanaka H; Matsumoto M; Takeda Y; Tamura Y; Nemori R; Yoshioka T
Clin Cancer Res; 2000 Aug; 6(8):3290-6. PubMed ID: 10955815
[TBL] [Abstract][Full Text] [Related]
15. Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
Sundelin K; Roberg K; Grénman R; Håkansson L
Acta Otolaryngol; 2005 Jul; 125(7):765-73. PubMed ID: 16012040
[TBL] [Abstract][Full Text] [Related]
16. Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.
Coletta RD; Cotrim P; Vargas PA; Villalba H; Pires FR; de Moraes M; de Almeida OP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):563-9. PubMed ID: 11346736
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
18. Functional role of matrix metalloproteinase-28 in the oral squamous cell carcinoma.
Lin MH; Liu SY; Su HJ; Liu YC
Oral Oncol; 2006 Oct; 42(9):907-13. PubMed ID: 16730219
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
20. Metalloproteinase expression in normal and malignant oral keratinocytes: stimulation of MMP-2 and -9 by scatter factor.
Bennett JH; Morgan MJ; Whawell SA; Atkin P; Roblin P; Furness J; Speight PM
Eur J Oral Sci; 2000 Aug; 108(4):281-91. PubMed ID: 10946762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
